270 related articles for article (PubMed ID: 32880724)
1. Feasibility and initial validation of 'HD-Mobile', a smartphone application for remote self-administration of performance-based cognitive measures in Huntington's disease.
McLaren B; Andrews SC; Glikmann-Johnston Y; Mercieca EC; Murray NWG; Loy C; Bellgrove MA; Stout JC
J Neurol; 2021 Feb; 268(2):590-601. PubMed ID: 32880724
[TBL] [Abstract][Full Text] [Related]
2. A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
Lipsmeier F; Simillion C; Bamdadian A; Tortelli R; Byrne LM; Zhang YP; Wolf D; Smith AV; Czech C; Gossens C; Weydt P; Schobel SA; Rodrigues FB; Wild EJ; Lindemann M
J Med Internet Res; 2022 Jun; 24(6):e32997. PubMed ID: 35763342
[TBL] [Abstract][Full Text] [Related]
3. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
4. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
[TBL] [Abstract][Full Text] [Related]
5. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
[TBL] [Abstract][Full Text] [Related]
6. Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.
Achenbach J; Matusch A; Elmenhorst D; Bauer A; Saft C
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740281
[TBL] [Abstract][Full Text] [Related]
7. Greater time in bed and less physical activity associate with poorer cognitive functioning performance in Huntington's disease.
McLaren B; Drummond SPA; Glikmann-Johnston Y; Loy C; Bellgrove MA; Stout JC; Andrews SC
Neuropsychology; 2021 Sep; 35(6):656-667. PubMed ID: 34292025
[No Abstract] [Full Text] [Related]
8. GEORGE®: A Pilot Study of a Smartphone Application for Huntington's Disease.
Waddell EM; Dinesh K; Spear KL; Elson MJ; Wagner E; Curtis MJ; Mitten DJ; Tarolli CG; Sharma G; Dorsey ER; Adams JL
J Huntingtons Dis; 2021; 10(2):293-301. PubMed ID: 33814455
[TBL] [Abstract][Full Text] [Related]
9. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
10. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
11. Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration.
Staffaroni AM; Clark AL; Taylor JC; Heuer HW; Sanderson-Cimino M; Wise AB; Dhanam S; Cobigo Y; Wolf A; Manoochehri M; Forsberg L; Mester C; Rankin KP; Appleby BS; Bayram E; Bozoki A; Clark D; Darby RR; Domoto-Reilly K; Fields JA; Galasko D; Geschwind D; Ghoshal N; Graff-Radford N; Grossman M; Hsiung GY; Huey ED; Jones DT; Lapid MI; Litvan I; Masdeu JC; Massimo L; Mendez MF; Miyagawa T; Pascual B; Pressman P; Ramanan VK; Ramos EM; Rascovsky K; Roberson ED; Tartaglia MC; Wong B; Miller BL; Kornak J; Kremers W; Hassenstab J; Kramer JH; Boeve BF; Rosen HJ; Boxer AL;
JAMA Netw Open; 2024 Apr; 7(4):e244266. PubMed ID: 38558141
[TBL] [Abstract][Full Text] [Related]
12. Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
Reyes A; Bartlett DM; Rankin TJ; Zaenker P; Turner K; Teo WP; Fu SC; Domingos J; Georgiou-Karistianis N; Ziman M; Cruickshank TM
Phys Ther; 2021 Apr; 101(4):. PubMed ID: 33482001
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Stout JC; Jones R; Labuschagne I; O'Regan AM; Say MJ; Dumas EM; Queller S; Justo D; Santos RD; Coleman A; Hart EP; Dürr A; Leavitt BR; Roos RA; Langbehn DR; Tabrizi SJ; Frost C
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):687-94. PubMed ID: 22566599
[TBL] [Abstract][Full Text] [Related]
14. Cognitive decline in Huntington's disease expansion gene carriers.
Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
[TBL] [Abstract][Full Text] [Related]
15. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
[TBL] [Abstract][Full Text] [Related]
16. The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington's disease individuals.
Júlio F; Caetano G; Januário C; Castelo-Branco M
Orphanet J Rare Dis; 2019 Nov; 14(1):246. PubMed ID: 31703597
[TBL] [Abstract][Full Text] [Related]
17. Smartphone-Based Neuropsychological Assessment in Parkinson's Disease: Feasibility, Validity, and Contextually Driven Variability in Cognition.
Weizenbaum EL; Fulford D; Torous J; Pinsky E; Kolachalama VB; Cronin-Golomb A
J Int Neuropsychol Soc; 2022 Apr; 28(4):401-413. PubMed ID: 33998438
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease.
Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P
Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946
[TBL] [Abstract][Full Text] [Related]
19. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
[TBL] [Abstract][Full Text] [Related]
20. Predictors of simulated driving performance in Huntington's disease.
Jacobs M; Hart EP; Mejia Miranda Y; Groeneveld GJ; van Gerven JMA; Roos RAC
Parkinsonism Relat Disord; 2019 Mar; 60():64-69. PubMed ID: 30292732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
